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ABSTRACT
Background: The use of cardiopulmonary bypass (CPB) may contribute to post-operative complications and organ dysfunction. 
Off pump coronary artery bypass grafting (OPCABG) avoids the use of CPB and hence is proposed to reduce these complications. 
We present the results of OPCABG in Northern Ireland over ten years.
Methods: Data was collected retrospectively from 1995 to 2005. Follow-up was done by telephonic questionnaire and from 
medical records within a closing interval of two months.
Results: 324 patients (224 male) underwent OPCABG with a median age of 62 years (range 35 to 79 years). There were 149 
patients with CCS class III/IV angina and 48 with NYHA class III/IV . 148 patients had suffered a myocardial infarction in the 
past. 36 patients had a pre-operative predictive mortality score (EuroSCORE) of >5 and 48 patients had a preoperative LVEF 
of <30%. 585 bypass grafts were constructed (LAD=260, Diagonal=27, LCX/OM=123, RCA/PDA=103, RCA/PLV=72). Four 
patients needed to be converted from OPCABG to CPB on table. Another four patients needed re-operation due to graft related 
problems in the post-operative period and 6 needed post-operative Intra-aortic Balloon Pump (IABP) support. Post-operative 
complications included 3 TIAs, 1 complete stroke, 9 patients with renal failure and 51 patients developed atrial fibrillation 
post operatively. There was one peri-operative death due to pulmonary edema.  Ninety percent of patients were in CCS angina 
class I/II and NYHA class I/II post-operatively. Forty one patients developed significant recurrence of angina requiring medical 
management, with 7 patients needing PCI/stenting. At the time of follow-up (median 5 years, range 3 months to 10 years) 9 
patients had died.
Conclusions: Off pump coronary artery bypass (OPCABG) can be achieved with a low mortality and good medium to long term 
survival. OPCABG is associated with fewer post-op complications and comparable late coronary interventions.
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INTRODUCTION
Coronary artery bypass grafting (CABG) or direct myocardial 
revascularisation involves the use of a vascular conduit to 
bypass atheromatous lesions in coronary arteries. The first 
recorded bypass operations were in the sixties when Goetz et 
al1 and Kolessov2 grafted pedicled internal mammary arteries 
to  the  right  coronary  artery  and  left  anterior  descending 
arteries  respectively.  These  operations  were  performed 
without the use of cardiopulmonary bypass also known as 
Off-pump coronary artery bypass grafting (OPCABG).
Development  of  Cardiopulmonary  bypass  (CPB)  and 
myocardial protection led to the development of myocardial 
revascularisation with cardioplegic arrest. This enabled cardiac 
surgeons to operate in a motionless and bloodless field; and 
so  OPCABG  was  relatively  abandoned  for  the  technical 
advantage that CPB and cardioplegic arrest offered.
CPB is associated with activation of the complement system 
and the coagulation cascades which may contribute to the 
varying degrees of organ damage reported in the literature3 4. 
Blood contact with the artificial surfaces of the CPB circuit 
produces a well-documented diffuse inflammatory response 
that  affects  multiple  organ  systems.  Specific  deleterious 
effects  of  the  inflammatory  response  have  been  found 
in  the  heart,  lungs,  central  nervous  system,  kidneys,  and 
gastrointestinal tract3. These unavoidable side effects of CPB 
have led to the renewal of interest in OPCABG. Significant 
technological advances made in the last decade have allowed 
OPCABG to be performed with good success rates without 
the risks of CPB. This paper presents a retrospective review 
of our results over a ten-year period.© The Ulster Medical Society, 2008.
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METHODS
All Patients who underwent OPCABG between September 
1995 and March 2005 were identified from theatre records 
(n=324). Demographic data was obtained from medical case 
notes  and  the  computerised  patient  data  system  (PATS). 
Formal  EuroSCORE5,  a  validated  predictor  of  operative 
mortality for cardiac surgical procedures, was calculated for 
each patient pre-operatively to predict the mortality. This 
scoring was introduced in 1999, and hence we included those 
patients who had the EuroSCORE computed pre-operatively 
and those who were operated by the senior authors (GC and 
PB) and excluded the rest of the patients (n=266). Operative 
variables recorded included: number of bypass grafts; type 
of conduit used; number of distal anastomoses; number of 
patients converted to CPB and the reasons for conversion. 
All the demographic, EuroSCORE and the procedure specific 
data were collected prospectively in this cohort of patients 
included for analysis, the post-discharge follow-up was done 
retrospectively.
All patients underwent an operation through a standard median 
sternotomy with the Left internal mammary artery (LIMA) 
harvested where indicated under direct vision. Heparin was 
administered at 2mg/kg prior to division of the mammary 
artery  with  supplemental  doses  to  maintain  adequate 
heparinisation (ACT, activated clotting time>250seconds); 
and reversed with protamine (1:1) after completion of the 
last  proximal  anastomosis. Aspirin  or  antiplatelet  therapy 
was stopped five days before operation and recommenced 
immediately after the operation. Subcutaneous Enoxaparin 
was  administered  at  40mg  twice  daily  post-operatively 
till  the  patients  were  mobile  for  deep  venous  thrombosis 
prophylaxis.
Commercially available mechanical stabilization devices such 
as the Octopus 2 (Medtronic Inc, Minneapolis, MN), CTS 
stabilizer (Guidant Inc) were used to stabilise the coronary 
targets on the beating heart; and pericardial traction sutures 
were  used  to  position  the  heart  where  appropriate.  The 
target  coronary  arteries  were  occluded  proximally  with  a 
temporary snare using a pledgeted 4-0 polypropylene suture. 
Retrograde bleeding was controlled with a sterile, humidified 
carbon dioxide blower (Medtronic DLP, Grand Rapids, MI). 
Intraluminal coronary shunts (Bio-Vascular, Inc, St. Paul, 
MN)  were  used  infrequently  (<  10%  of  patients)  when 
retrograde bleeding was excessive or when it was anticipated 
that occlusion of a coronary target would be poorly tolerated 
because of critical ischaemia.
Distal  anastomoses  were  constructed  with  a  continuous 
running  7-0  polypropylene  suture.  Proximal  anastomoses 
were sewn to the aorta under a partial occlusion clamp with 
a continuous 6-0 polypropylene suture. All patients received 
postoperative care in the same Cardiac Surgery Intensive Care 
Unit (CSICU) with early extubation where appropriate, the 
aim being discharge by day 6.
Definitions of co-morbidities/complications:
Postoperative  variables  recorded  included  creatine  kinase 
isoenzyme MB (CK-MB) (as an indicator of peri-operative 
myocardial  injury,  with  absolute  increase  of  more  than 
10%  compared  to  creatine  kinase  levels);  changes  in  the 
morphology of ST segment indicating ischaemia or infarction; 
incidence of ishaemic ventricular arrhythmias; Intra-Aortic 
Balloon pump (IABP) use and inotropic requirement as an 
indicator of myocardial dysfunction. Pulmonary dysfunction 
is defined as the long term use of bronchodilators or steroids 
for lung disease or prolonged ventilatory dependence due to 
pneumonia or ARDS. Neurological dysfunction is defined as 
neurological disease severely affecting ambulation or day-
to-day functioning. Transient Ischaemic Attacks (TIAs) are 
neurological events with the signs and symptoms of a stroke 
which resolve completely within 24 hours. Renal failure is 
defined as anuria or oliguria (<10ml/hr) (with an adequate 
mean BP) and renal impairment is a serum creatinine >200 
micromol/l or need for renal replacement therapy. Follow-
up was done by telephonic questionnaire (within a closing 
interval of 2 months) and from medical records.
Statistical analysis: 
For  normally  distributed  data  the  mean  and  standard 
deviations  are  expressed.  Fisher  exact  test  was  used  to 
determine  significance  between  categorical  variables  and 
Mann Whitney U test for continuous variables. Binary logistic 
regression with confirmation by forward method was used for 
the multivariate analysis.
RESULTS
Analyses  revealed  324  patients  (224  male)  to  have  had 
OPCABG in the Royal Victoria Hospital between Sept 1995 
and March 2005. Mean age was 62 (range 35 – 79). The study 
population consisted of 266 patients as outlined above, with 
a EuroSCORE median of 3 (range 1 – 8). Thirty six patients 
had a EuroScore5 of more than five. There were 149 patients 
with CCS class III/IV angina (angina with mild exertion/
angina  at  rest)  and  48  with  NYHA  class  III/IV  (marked 
limitation of physical activity/unable to carry out any physical 
activity  without  discomfort).  148  patients  had  suffered 
previous myocardial infarction (MI) and 48 patients had a 
preoperative left ventricular ejection fraction (LVEF) of <30% 
on echocardiography or as estimated by ventriculogram.
A total of 585 bypass grafts were performed (Left anterior 
descending  branch  (LAD)  =  260,  Diagonal  branch  =  27, 
Obtuse marginal branch = 123, Posterior descending artery 
branch = 103, Posterior left ventricular branch = 72). The 
average number of grafts per patient was 2 (range 1 – 4) 
with a LIMA to LAD graft in 242(75%) of patients. Four 
patients had their operations converted to CPB; three for 
unstable haemodynamics and one for myocardial optimisation 
following  a  myocardial  infarction  intra-operatively. There 
were 2 peri-operative myocardial infarctions, 1 discovered 
on  the  operating  table  as  above,  the  other  detected  post-
operatively from CK-MB measurements. Four patients needed 
re-operation due to graft related problems in the peri-operative 
period, 6 patients required an intra-aortic balloon pump peri-
operatively for haemodynamic instability including 1 post-
operative death due to pulmonary oedema.
The median chest drainage was 781ml (range 130 to 2483ml). 
Median ventilatory time was 18 hours (range 2 to 168 hours). 
Four  patients  suffered  cerebrovascular  accidents  (CVAs) 
peri-operatively; 3 were confirmed as TIAs and recovered 
fully prior to discharge and 1 patient had a complete stroke. © The Ulster Medical Society, 2008.
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Fifty one patients developed transient atrial fibrillation post-
operatively  one  of  which  was  from  chronic  pre-operative 
atrial fibrillation. Nine patients developed post-operative renal 
failure one of which was known to have renal impairment 
pre-operatively and had a nephrectomy 7 years earlier. There 
were 6 wound infections post-operatively, one of which had 
a sternotomy wound dehiscence with mediastinitis and was 
successfully treated with debridement and rewiring.
At follow-up most patients (90%) were in CCS class I/II 
and NYHA class I/II post-operatively. A total of 41 patients 
developed a recurrence of angina, with seven needing PCI/
stenting, the rest were well controlled medically. At the time 
of follow-up (median 5 years, range 3 months to 10 years) 9 
patients had died.
Surgery in high risk patients:
The high risk group is defined as having one or more of the 
following: Age>75(n=8), LVEF<30% (n=48), MI within 6 
weeks (n=7), pre-operative neurological dysfunction (n=5), 
pre-operative pulmonary dysfunction (n=6) and pre-operative 
renal impairment (n=7). We excluded (n=6) patients who had 
a non-cardiac procedure carried out together with OPCABG. 
We compared our results of OPCABG between the high-risk 
and low risk patients to see if there was any difference in the 
frequency of adverse events. 
There were five patients who had more than two selection 
criteria  for  high-risk.  Amongst  high-risk  patients,  one 
developed CVA, two patients had pneumonia and two had 
transient  renal  failure  not  necessitating  dialysis  (adverse 
events) but none of the patients died in the perioperative 
period. One patient in low risk suddenly collapsed 3months 
after surgery, two patients in the high-risk group died, one 
due to a ruptured aortic aneurysm within 6months of surgery 
(which was known prior to his operation) and other due to a 
CVA and subsequent development of septicemia 10 months 
post-surgery. (Table I)
DISCUSSION
This  retrospective  review  presents  the  first  report  of  the 
results of OPCABG in the province over ten years. Various 
modifications and technological advances over this period 
now allow the safe performance of OPCABG in more groups 
of  patients  that  previously  would  have  been  considered 
unsuitable. Numerous studies have demonstrated the safety 
and efficacy of OPCABG with favourable early outcomes 
and a recent meta-analysis revealed that OPCABG is a safe 
alternative to conventional CABG with respect to mortality, 
and is recommended to reduce perioperative morbidity6. We 
have demonstrated that using this technique, success rates 
(mortality)  are  comparable  to  conventional  CABG  using 
CPB.
OPCABG is unsuitable for patients with a severely dilated or 
hypertrophied heart; patients in cardiogenic shock; patients 
with mechanical complications of myocardial infarction like 
post-infarct ventricular septal defects (post-infarct VSD) and 
patients who may need concomitant valve procedures. In these 
cases the preferred method would be CABG with CPB. There 
is always the option to convert an OPCABG to conventional 
CABG for a number of reasons which include myocardial 
instability  intra-operatively,  intra-myocardial  coronary 
arteries or difficult access to target vessels; but with modern 
technology and techniques this rarely happens.
A consensus is now emerging as to the appropriate application 
of OPCABG to benefit patients with a pre-operative risk of 
developing neurological dysfunction. These included patients 
with extensive carotid artery disease who have a high risk 
of developing a perioperative stroke4. OPCABG is ideally 
suited for patients who have an atherosclerotic aorta where 
manipulation of the aorta can be avoided by using bilateral 
internal  mammary  arteries  with T  configuration  grafts  to 
avoid the proximal anastomosis of the aorta. Patients with 
documented renal impairment who may be at increased risk 
of developing further renal damage, secondary to hypotension 
due  to  CPB,  also  benefit  from  OPCABG.  The  literature 
observes a trend towards a reduced need for blood transfusions, 
earlier weaning from ventilation and earlier discharge with 
the use of OPCABG even when it is employed in the elderly 
patient and in patients with several co-morbid conditions4 6 7. 
Currently, about 20% of surgical coronary revascularization 
at the national level is performed using OPCABG8. OPCABG 
is a useful strategy in the armamentarium of a modern cardiac 
surgeon and in carefully selected patients has proven benefit 
Ta b l e  I: 
Comparison of the outcomes in a high risk group versus low risk group
Variable Low-risk (n=73) High Risk (n=58) P value
Pre-op Neurological disease 1 5 0.08
Pre-op Renal impairment 1 7 <0.05
Pre-op Pulmonary disease 1 6 0.069
No of grafts 2.08(1-4) 2.24(1-3) NS
Post-op CKMB 25(3-460) 30(3-187) 0.44
Ventilation (hours) 16.24(3-240) 15.87(4-24) 0.042
Blood loss (mls) 730(200-2430) 750(240-2000) 0.57
Hospital stay (days) 7.4(4-46) 7(4-19) 0.58
Adverse events 1 5 0.08
Late re-intervention 2 4 0.19© The Ulster Medical Society, 2008.
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with improved outcomes.
The outcomes of low risk patients and high risk patients were 
comparable (Table I). These high risk patients would have 
been expected to have a higher degree of complications and 
adverse events if they underwent conventional CABG with 
CPB.
This was a retrospective review and was not randomised so 
there is a selection bias for OPCABG. We cannot conclude 
from  this  study  that  OPCABG  is  a  better  alternative  to 
CABG with CBP but we show that it is a successful and 
comparative option in surgical revascularisation of diseased 
coronary arteries. Due to advances in medical therapy older 
and  sicker  patients  with  other  co-morbid  conditions  are 
referred  for  coronary  bypass  operations.  This  means  an 
increasing proportion of patients may present with relative 
contraindications to CPB such as renal impairment and an 
increased risk of cerebrovascular accidents. For such patients 
a successful alternative is OPCABG.
The authors have no conflict of interest.
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